GSK Operating Income 2010-2023 | GSK
GSK annual/quarterly operating income history and growth rate from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- GSK operating income for the quarter ending March 31, 2023 was $2.529B, a 32.7% decline year-over-year.
- GSK operating income for the twelve months ending March 31, 2023 was $6.728B, a 32.39% decline year-over-year.
- GSK annual operating income for 2022 was $7.957B, a 6.68% decline from 2021.
- GSK annual operating income for 2021 was $8.527B, a 14.67% decline from 2020.
- GSK annual operating income for 2020 was $9.993B, a 12.43% increase from 2019.
GSK Annual Operating Income
(Millions of US $) |
| 2022 |
$7,957 |
| 2021 |
$8,527 |
| 2020 |
$9,993 |
| 2019 |
$8,889 |
| 2018 |
$7,319 |
| 2017 |
$5,267 |
| 2016 |
$3,521 |
| 2015 |
$15,782 |
| 2014 |
$5,417 |
| 2013 |
$10,392 |
| 2012 |
$11,717 |
| 2011 |
$12,526 |
| 2010 |
$5,850 |
| 2009 |
$13,193 |
GSK Quarterly Operating Income
(Millions of US $) |
| 2023-03-31 |
$2,529 |
| 2022-12-31 |
$1,439 |
| 2022-09-30 |
$1,403 |
| 2022-06-30 |
$1,357 |
| 2022-03-31 |
$3,758 |
| 2021-12-31 |
$1,179 |
| 2021-09-30 |
$2,672 |
| 2021-06-30 |
$2,341 |
| 2021-03-31 |
$2,335 |
| 2020-12-31 |
$1,477 |
| 2020-09-30 |
$2,400 |
| 2020-06-30 |
$3,537 |
| 2020-03-31 |
$2,580 |
| 2019-12-31 |
$2,473 |
| 2019-09-30 |
$2,647 |
| 2019-06-30 |
$1,908 |
| 2019-03-31 |
$1,860 |
| 2018-12-31 |
$1,368 |
| 2018-09-30 |
$2,489 |
| 2018-06-30 |
$1,060 |
| 2018-03-31 |
$2,401 |
| 2017-12-31 |
$707 |
| 2017-09-30 |
$2,457 |
| 2017-06-30 |
$-26 |
| 2017-03-31 |
$2,128 |
| 2016-12-31 |
$740 |
| 2016-09-30 |
$1,879 |
| 2016-06-30 |
$-217 |
| 2016-03-31 |
$1,036 |
| 2015-12-31 |
$13,361 |
| 2015-09-30 |
$1,434 |
| 2015-06-30 |
$420 |
| 2015-03-31 |
$636 |
| 2014-12-31 |
$-57 |
| 2014-09-30 |
$1,358 |
| 2014-06-30 |
$1,754 |
| 2014-03-31 |
$1,798 |
| 2013-12-31 |
$3,669 |
| 2013-09-30 |
$2,714 |
| 2013-06-30 |
$2,159 |
| 2013-03-31 |
$2,168 |
| 2012-12-31 |
$3,566 |
| 2012-09-30 |
$2,853 |
| 2012-06-30 |
$2,621 |
| 2012-03-31 |
$3,002 |
| 2011-12-31 |
$3,723 |
| 2011-09-30 |
$3,115 |
| 2011-06-30 |
$2,783 |
| 2011-03-31 |
$2,752 |
| 2010-12-31 |
$-270 |
| 2010-09-30 |
$3,036 |
| 2010-06-30 |
$-1,208 |
| 2010-03-31 |
$3,068 |
| 2009-12-31 |
$4,080 |
| 2009-09-30 |
$3,402 |
| 2009-06-30 |
$3,480 |
| 2009-03-31 |
$2,384 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$69.839B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
